The DiviOmics platform offers its services to research teams or private sector players, whether national or international.
The platform offers a broad spectrum of analyzes covering scientific fields as varied as lipid metabolism, cardiovascular diseases, diabetes, sepsis, inflammation, cancer, Alzheimer's, graft versus host diseases, intercellular communication (extracellular vesicles).
Alongside this activity in human health, the platform offers other types of analyzes whether in animal biology or in plant biology and can develop custom dosages in line with your specific needs.
Activity directed both towards the academic world
- network of around sixty teams -
And towards the private sector
A diversified service activity serving private sector partners:
Activity towards the private sector is developed within the framework of SATT Sayens. In particular, the platform has offered since 2013 the patented EndoQuant assay for targeted quantification of bacterial endotoxins (or LPS) by mass spectrometry.